by Surgical disinfectants are used widely during surgeries and other medical procedures to prevent nosocomial or hospital-acquired infections. These products help eliminate microorganisms and pathogens through disinfection of medical equipment, devices, and surfaces. With increasing number of surgeries and heightened awareness about infection control practices, the demand for hospital disinfectants is growing significantly. Some of the commonly used disinfectants include alcohols, aldehydes, oxidizing agents, phenols, and quaternary ammonium compounds which are effective against bacteria, viruses and fungi. The global hospital surgical disinfectants market offers a wide range of disinfectant solutions suitable for pre-operative, intra-operative and post-operative applications. The rising prevalence of chronic diseases and growth in geriatric population has augmented surgical procedures worldwide, thereby propelling the market growth.
The global Hospital Surgical Disinfectants Market is estimated to be valued at US$ 21.2 Bn in 2030 and is expected to exhibit a CAGR of 17% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends witnessed in the hospital surgical disinfectants market is the increasing demand for eco-friendly products. Strict regulations have compelled manufacturers to develop disinfectants which are non-toxic and do not release harmful by-products. Many companies are focusing on utilizing green chemistry principles and sourcing renewable raw materials to manufacture disinfectants. Hydrogen peroxide and peracetic acid based formulations are emerging as sustainable alternatives to traditional aldehydes and oxidizers. Natural and plant-derived ingredients are also being widely researched and developed as future green disinfectants. This shift towards safer chemistries is expected to define new growth opportunities and directions in the market over the coming years.
Porter’s Analysis
Threat of new entrants: The threat is moderate as significant capital investment is required to enter the market for R&D, manufacturing facilities and geographic expansion. However, opportunities exist for new entrants to develop new and innovative disinfectant products.
Bargaining power of buyers: The bargaining power is high since hospitals can negotiate for lower prices and value-added services from manufacturers. Buyers can also chose substitutable products from other suppliers.
Bargaining power of suppliers: The bargaining power of suppliers is moderate. Key raw materials suppliers include companies providing active ingredients, packaging materials etc. Supplier switching costs are low.
Threat of new substitutes: The threat is moderate as new substitute products can be developed. However, proving efficacy and safety of new products takes significant time and investment.
Competitive rivalry: The competition is high among existing players to gain market share by expanding their product portfolios and improving product quality.
Key Takeaways
Global Hospital Surgical Disinfectants Market Demand is expected to witness high growth.
Regional analysis shows North America dominates the market currently owing to rising healthcare expenditure and awareness about hospital-acquired infections. Europe and Asia Pacific are fastest growing markets driven by growing medical tourism and healthcare infrastructure development.
Key players operating in the hospital surgical disinfectants market are 3M Company, Johnson & Johnson, Procter & Gamble, Reckitt Benckiser Group plc, The Clorox Company, Kimberly-Clark Corporation, Cantel Medical Corporation, Ecolab and Whiteley Corporation. These players are focusing on new product launches and strategic acquisitions to strengthen their market position.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
